137 related articles for article (PubMed ID: 36028084)
21. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
Gleeson JP; Frías JM; Ryan SM; Brayden DJ
Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
[TBL] [Abstract][Full Text] [Related]
22. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
23. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology.
Chao AC; Nguyen JV; Broughall M; Griffin A; Fix JA; Daddona PE
Int J Pharm; 1999 Nov; 191(1):15-24. PubMed ID: 10556736
[TBL] [Abstract][Full Text] [Related]
25. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
[TBL] [Abstract][Full Text] [Related]
26. Intestinal absorptivity-increasing effects of sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate on food-derived bioactive peptide.
Xu Y; Amakye WK; Xiao G; Liu X; Ren J; Wang M
Food Chem; 2023 Feb; 401():134059. PubMed ID: 36095999
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
Aguirre TA; Rosa M; Coulter IS; Brayden DJ
Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
[TBL] [Abstract][Full Text] [Related]
28. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats.
Fan D; Wu X; Dong W; Sun W; Li J; Tang X
Drug Dev Ind Pharm; 2013 Sep; 39(9):1447-56. PubMed ID: 23020091
[TBL] [Abstract][Full Text] [Related]
29. Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
Tomono T; Yagi H; Ukawa M; Ishizaki S; Miwa T; Nonomura M; Igi R; Kumagai H; Miyata K; Tobita E; Kobayashi H; Sakuma S
Eur J Pharm Biopharm; 2020 Sep; 154():186-194. PubMed ID: 32681963
[TBL] [Abstract][Full Text] [Related]
30. Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat.
Chiang PC; Liu J; Nagapudi K; Wu R; Dolton M; Chen J; Plise E; Liu L; Durk MR
J Pharm Sci; 2022 Dec; 111(12):3417-3423. PubMed ID: 36228756
[TBL] [Abstract][Full Text] [Related]
31. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
32. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
33. Evaluation in pig of an intestinal administration device for oral peptide delivery.
Berg S; Uggla T; Antonsson M; Nunes SF; Englund M; Rosengren L; Fahraj M; Wu X; Govender R; Söderberg M; Janzén D; Van Zuydam N; Hugerth A; Larsson A; Abrahmsén-Alami S; Abrahamsson B; Davies N; Bergström CAS
J Control Release; 2023 Jan; 353():792-801. PubMed ID: 36493948
[TBL] [Abstract][Full Text] [Related]
34. Intestinal Absorption of FITC-Dextrans and Macromolecular Model Drugs in the Rat Intestinal Instillation Model.
Berg S; Suljovic D; Kärrberg L; Englund M; Bönisch H; Karlberg I; Van Zuydam N; Abrahamsson B; Hugerth AM; Davies N; Bergström CAS
Mol Pharm; 2022 Jul; 19(7):2564-2572. PubMed ID: 35642793
[TBL] [Abstract][Full Text] [Related]
35. Experiences and Translatability of
Emeh P; Breitholtz K; Berg S; Vedin C; Englund M; Uggla T; Antonsson M; Nunes F; Hilgendorf C; Bergström CAS; Davies N
Mol Pharm; 2024 Jan; 21(1):313-324. PubMed ID: 38054599
[TBL] [Abstract][Full Text] [Related]
36. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
Constantinides PP; Welzel G; Ellens H; Smith PL; Sturgis S; Yiv SH; Owen AB
Pharm Res; 1996 Feb; 13(2):210-5. PubMed ID: 8932438
[TBL] [Abstract][Full Text] [Related]
37. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs.
Raoof AA; Ramtoola Z; McKenna B; Yu RZ; Hardee G; Geary RS
Eur J Pharm Sci; 2002 Nov; 17(3):131-8. PubMed ID: 12393140
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.
Alani AW; Robinson JR
Pharm Res; 2008 Jan; 25(1):48-54. PubMed ID: 17846867
[TBL] [Abstract][Full Text] [Related]
39. Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.
Arafat M; Kirchhoefer C; Mikov M
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):635-645. PubMed ID: 27686853
[TBL] [Abstract][Full Text] [Related]
40. Interaction between dietary bioactive peptides of short length and bile salts in submicellar or micellar state.
Guerin J; Kriznik A; Ramalanjaona N; Le Roux Y; Girardet JM
Food Chem; 2016 Oct; 209():114-22. PubMed ID: 27173542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]